---
title: "港股醫藥股午後跌幅擴大，騰盛博藥跌超 16%，三葉草生物跌超 10%，君實生物跌超 7%。"
description: "港股醫藥股午後跌幅擴大，騰盛博藥跌超 16%，三葉草生物跌超 10%，君實生物跌超 7%。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/65187796.md"
published_at: "2022-07-12T06:53:03.000Z"
---

# 港股醫藥股午後跌幅擴大，騰盛博藥跌超 16%，三葉草生物跌超 10%，君實生物跌超 7%。

港股醫藥股午後跌幅擴大，騰盛博藥跌超 16%，三葉草生物跌超 10%，君實生物跌超 7%。

### Related Stocks

- [02137.HK - 騰盛博藥-B](https://longbridge.com/zh-HK/quote/02137.HK.md)
- [02197.HK - 三葉草生物-B](https://longbridge.com/zh-HK/quote/02197.HK.md)
- [01877.HK - 君實生物](https://longbridge.com/zh-HK/quote/01877.HK.md)
- [688180.CN - 君實生物-U](https://longbridge.com/zh-HK/quote/688180.CN.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| CICC Reaffirms Their Buy Rating on Suzhou Ribo Life Science Co., Ltd. Class H (6938) | In a report released yesterday, from CICC maintained a Buy rating on Suzhou Ribo Life Science Co., Ltd. Class H, with a  | [Link](https://longbridge.com/zh-HK/news/276199846.md) |
| 4-Olympics-Figure skating-Miura and Kihara skate to Japan's first ever Olympic pairs title | Riku Miura and Ryuichi Kihara made history by winning Japan's first Olympic figure skating pairs title at the Milano Cor | [Link](https://longbridge.com/zh-HK/news/276085111.md) |
| Tesla's January Sales Drop 17%, But Its Market Share May Have Risen | Tesla's U.S. electric vehicle sales dropped 17% in January, continuing a downward trend exacerbated by the end of the fe | [Link](https://longbridge.com/zh-HK/news/275942023.md) |
| Olympics-Figure Skating-Japan’s Miura and Kihara slip to fifth after lift error, eye comeback in free skate | Japanese figure skating pair Riku Miura and Ryuichi Kihara finished fifth in the short programme at the Milano Cortina O | [Link](https://longbridge.com/zh-HK/news/276018749.md) |
| Trump says will require voter ID for midterms regardless of Congress | U.S. President Donald Trump announced that voter ID requirements will be enforced for the midterm elections in November, | [Link](https://longbridge.com/zh-HK/news/275948677.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。